Cargando…
Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma
BACKGROUND: The advent of molecular medicine may allow for individualized cancer prognostication, which should enable better clinical management and, hopefully, improve patient outcomes. A 31-gene expression profile (31-GEP) test is currently available for patients diagnosed with cutaneous melanoma;...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872504/ https://www.ncbi.nlm.nih.gov/pubmed/31359351 http://dx.doi.org/10.1007/s40257-019-00464-4 |